These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15122736)
1. Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome. Moskowitz CS; Pepe MS Stat Med; 2004 May; 23(10):1555-70. PubMed ID: 15122736 [TBL] [Abstract][Full Text] [Related]
2. Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes. Moskowitz CS; Pepe MS Biostatistics; 2004 Jan; 5(1):113-27. PubMed ID: 14744831 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. Rao NY; Hu Z; Yu JM; Li WF; Zhang B; Su FX; Wu J; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 Aug; 116(3):563-70. PubMed ID: 18807178 [TBL] [Abstract][Full Text] [Related]
4. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. Veronesi A; de Giacomi C; Magri MD; Lombardi D; Zanetti M; Scuderi C; Dolcetti R; Viel A; Crivellari D; Bidoli E; Boiocchi M BMC Cancer; 2005 Jul; 5():70. PubMed ID: 15996267 [TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Antoniou AC; Durocher F; Smith P; Simard J; Easton DF; Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652 [TBL] [Abstract][Full Text] [Related]
6. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Pierce LJ; Levin AM; Rebbeck TR; Ben-David MA; Friedman E; Solin LJ; Harris EE; Gaffney DK; Haffty BG; Dawson LA; Narod SA; Olivotto IA; Eisen A; Whelan TJ; Olopade OI; Isaacs C; Merajver SD; Wong JS; Garber JE; Weber BL J Clin Oncol; 2006 Jun; 24(16):2437-43. PubMed ID: 16636335 [TBL] [Abstract][Full Text] [Related]
7. Limits of predictive models using microarray data for breast cancer clinical treatment outcome. Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654 [TBL] [Abstract][Full Text] [Related]
8. Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates. Schoop R; Graf E; Schumacher M Biometrics; 2008 Jun; 64(2):603-10. PubMed ID: 17764480 [TBL] [Abstract][Full Text] [Related]
9. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data. Gui J; Li H Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556 [TBL] [Abstract][Full Text] [Related]
10. Factors increasing local recurrence in breast-conserving surgery. Fatouros M; Roukos DH; Arampatzis I; Sotiriadis A; Paraskevaidis E; Kappas AM Expert Rev Anticancer Ther; 2005 Aug; 5(4):737-45. PubMed ID: 16111473 [TBL] [Abstract][Full Text] [Related]
11. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083 [TBL] [Abstract][Full Text] [Related]
12. Non-linear survival analysis using neural networks. Ripley RM; Harris AL; Tarassenko L Stat Med; 2004 Mar; 23(5):825-42. PubMed ID: 14981677 [TBL] [Abstract][Full Text] [Related]
13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ; J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670 [TBL] [Abstract][Full Text] [Related]
14. Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis. Bassi P; Sacco E; De Marco V; Aragona M; Volpe A BJU Int; 2007 May; 99(5):1007-12. PubMed ID: 17437435 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer. Neri A; Marrelli D; Roviello F; De Stefano A; Guarnieri A; Pallucca E; Pinto E Ann Surg Oncol; 2005 Mar; 12(3):246-53. PubMed ID: 15827817 [TBL] [Abstract][Full Text] [Related]
16. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
17. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904 [TBL] [Abstract][Full Text] [Related]
18. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344 [TBL] [Abstract][Full Text] [Related]
19. Robust combination of multiple diagnostic tests for classifying censored event times. Cai T; Cheng S Biostatistics; 2008 Apr; 9(2):216-33. PubMed ID: 18056687 [TBL] [Abstract][Full Text] [Related]
20. Predicting features of breast cancer with gene expression patterns. Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]